The new coronavirus pneumonia is an acute infectious pneumonia. The pathogen is a previously unknown new coronavirus, namely 2019 new coronavirus (2019 novel coronavirus, 2019 nCoV). However, there is no specific anti-viral drug. It has been found that the specific antibodies against virus antigen are produced after these patients were cured, which could block the infection of 2019 nCoV on the host cells. At present, immunoadsorption is the most direct, rapid and effective method to separate immunoglobulin from the cured patients. Therefore, the study aims to prepare the immunoglobulin from 2019-ncov pneumonia cured patients, evaluate the efficacy and safety of the immunoglobulin in 2019-ncov pneumonia cured patients on the treatment of acute severe 2019-ncov pneumonia, and provide a new strategy for the treatment of 2019-ncov pneumonia.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
10
0.2g/kg, ivdrip, once a day, for 3 days
0.2g/kg, ivdrip, once a day, for 3 days
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Time to Clinical Improvement (TTCI)
TTCI is defined as the time (in days) from initiation of study treatment (active or placebo) until a decline of two categories from admission status on a six-category ordinal scale of clinical status which ranges from 1 (discharged) to 6 (death). Six-category ordinal scale: 6. Death; 5. ICU, requiring ECMO and/or IMV; 4. ICU/hospitalization, requiring NIV/ HFNC therapy; 3. Hospitalization, requiring supplemental oxygen (but not NIV/ HFNC); 2. Hospitalization, not requiring supplemental oxygen; 1. Hospital discharge. Abbreviation: IMV, invasive mechanical ventilation; NIV, non-invasive mechanical ventilation; HFNC, High-flow nasal cannula.
Time frame: up to 28 days
Clinical status assessed by the ordinal scale
on days 7, 14, 21, and 28
Time frame: up to 28 days
The differences in oxygen intake methods
1\. No need for supplemental oxygenation; 2. nasal cathete oxygen inhalation；3. Mask oxygen inhalation；4. Noninvasive ventilator oxygen supply；5. Invasive ventilator oxygen supply.
Time frame: up to 28 days
Duration (days) of supplemental oxygenation
Time frame: up to 28 days
Duration (days) of mechanical ventilation
Time frame: up to 28 days
The mean PaO2/FiO2
Time frame: up to 28 days
The lesions of the pulmonary segment numbers involved in pulmonary CT [ every 7 days]
The detection frequency could be increased according to clinician's decision
Time frame: up to 28 days
Time to 2019-nCoV RT-PCR negativity in respiratory tract specimens [every 3 days]
Time frame: up to 28 days
Dynamic changes of 2019-nCoV antibody titer in blood
The antibody titer is detected on days 3 and 28
Time frame: up to 28 days
Length of hospital stay (days)
Time frame: up to 28 days
All cause mortality
Time frame: up to 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.